Corbus Pharmaceuticals Holdings, Inc. Depreciation
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Depreciation of $50.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-06
- Corbus Pharmaceuticals Holdings, Inc. depreciation for the quarter ending 2026-06-30 was $50.00K, a 50.00% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. depreciation for the quarter ending 2026-03-31 was $49.00K, a 51.00% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. depreciation for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. depreciation for the quarter ending 2025-09-30 was $100.00K, a 50.00% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. depreciation for fiscal 2025 was $200.00K, a 66.67% decline from fiscal 2024.
- Corbus Pharmaceuticals Holdings, Inc. depreciation for fiscal 2024 was $600.00K, a 0.00% change from fiscal 2023.
- Corbus Pharmaceuticals Holdings, Inc. depreciation for fiscal 2023 was $600.00K, a 21.36% decline from fiscal 2022.
- Corbus Pharmaceuticals Holdings, Inc. depreciation for fiscal 2022 was $763.00K, a 23.70% decline from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $50.00K 10-Q · filed 2026-08-06 | $100.00K 10-Q · filed 2026-08-06 | $99.00K derived: sum of 3 quarters · filed 2026-08-06 | $199.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $49.00K 10-Q · filed 2026-05-12 | $49.00K derived: sum of 2 quarters · filed 2026-05-12 | $149.00K derived: sum of 3 quarters · filed 2026-05-12 | $249.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $100.00K derived: sum of 2 quarters · filed 2026-03-09 | $200.00K derived: sum of 3 quarters · filed 2026-08-06 | $200.00K 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-12 | $200.00K derived: sum of 2 quarters · filed 2026-08-06 | $200.00K 10-Q · filed 2025-11-12 | $400.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $100.00K 10-Q · filed 2026-08-06 | $100.00K 10-Q · filed 2026-08-06 | $300.00K derived: sum of 3 quarters · filed 2026-08-06 | $500.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $100.00K 10-Q · filed 2026-05-12 | $200.00K derived: sum of 2 quarters · filed 2026-05-12 | $400.00K derived: sum of 3 quarters · filed 2026-05-12 | $600.00K derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $300.00K derived: sum of 2 quarters · filed 2026-03-09 | $500.00K derived: sum of 3 quarters · filed 2026-03-09 | $600.00K 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | $200.00K 10-Q · filed 2025-11-12 | $400.00K derived: sum of 2 quarters · filed 2025-11-12 | $500.00K 10-Q · filed 2025-11-12 | $700.00K derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $200.00K 10-Q · filed 2025-08-05 | $300.00K 10-Q · filed 2025-08-05 | $500.00K derived: sum of 3 quarters · filed 2025-08-05 | $700.00K derived: sum of 4 quarters · filed 2025-08-05 | ||||
| 2024-03-31 | $200.00K 10-Q · filed 2025-05-06 | $151.69K 10-Q · filed 2024-05-07 | $300.00K derived: sum of 2 quarters · filed 2025-05-06 | $500.00K derived: sum of 3 quarters · filed 2025-05-06 | $700.00K derived: sum of 4 quarters · filed 2025-05-06 | |||
| 2023-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $300.00K derived: sum of 2 quarters · filed 2025-03-11 | $500.00K derived: sum of 3 quarters · filed 2025-03-11 | $600.00K 10-K · filed 2025-03-11 | $641.00K 10-K · filed 2024-03-12 | |||
| 2023-09-30 | $200.00K 10-Q · filed 2024-11-07 | $152.81K 10-Q · filed 2023-11-07 | $400.00K derived: sum of 2 quarters · filed 2024-11-07 | $500.00K 10-Q · filed 2024-11-07 | $493.02K 10-Q · filed 2023-11-07 | $766.27K derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | $200.00K 10-Q · filed 2024-08-06 | $158.34K 10-Q · filed 2023-08-08 | $300.00K 10-Q · filed 2024-08-06 | $340.21K 10-Q · filed 2023-08-08 | $566.27K derived: sum of 3 quarters · filed 2024-08-06 | $757.07K derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | $181.87K 10-Q · filed 2024-05-07 | $366.27K derived: sum of 2 quarters · filed 2024-05-07 | $557.07K derived: sum of 3 quarters · filed 2024-05-07 | $749.15K derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | $184.40K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $375.20K derived: sum of 2 quarters · filed 2024-03-12 | $567.28K derived: sum of 3 quarters · filed 2024-03-12 | $763.00K 10-K · filed 2024-03-12 | ||||
| 2022-09-30 | $190.79K 10-Q · filed 2023-11-07 | $382.88K derived: sum of 2 quarters · filed 2023-11-07 | $578.60K 10-Q · filed 2023-11-07 | $786.47K derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | $192.08K 10-Q · filed 2023-08-08 | $387.80K 10-Q · filed 2023-08-08 | $595.67K derived: sum of 3 quarters · filed 2023-08-08 | $851.96K derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | $195.72K 10-Q · filed 2023-05-09 | $403.59K derived: sum of 2 quarters · filed 2023-05-09 | $659.87K derived: sum of 3 quarters · filed 2023-05-09 | $923.53K derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $207.87K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $464.15K derived: sum of 2 quarters · filed 2023-03-07 | $727.81K derived: sum of 3 quarters · filed 2023-03-07 | $1.00M 10-K · filed 2023-03-07 | ||||
| 2021-09-30 | $256.29K 10-Q · filed 2022-11-08 | $519.95K derived: sum of 2 quarters · filed 2022-11-08 | $792.13K 10-Q · filed 2022-11-08 | $1.07M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $263.66K 10-Q · filed 2022-08-09 | $535.85K 10-Q · filed 2022-08-09 | $818.09K derived: sum of 3 quarters · filed 2022-08-09 | $1.02M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | $272.19K 10-Q · filed 2022-05-10 | $554.43K derived: sum of 2 quarters · filed 2022-05-10 | $756.51K derived: sum of 3 quarters · filed 2022-05-10 | $1.08M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $282.25K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $484.32K derived: sum of 2 quarters · filed 2022-03-08 | $804.51K derived: sum of 3 quarters · filed 2022-03-08 | $1.12M 10-K · filed 2022-03-08 | ||||
| 2020-09-30 | $202.08K 10-Q · filed 2021-11-12 | $522.27K derived: sum of 2 quarters · filed 2021-11-12 | $841.75K 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | $320.19K 10-Q · filed 2021-08-12 | $639.68K 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | $319.49K 10-Q · filed 2021-05-13 | |||||||
| 2019-12-31 | $739.00K 10-K · filed 2021-03-15 | |||||||
| 2017-06-30 | $32.96K 10-Q · filed 2017-08-09 | $64.45K 10-Q · filed 2017-08-09 | $94.76K derived: sum of 3 quarters · filed 2017-08-09 | $115.22K derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2017-03-31 | $31.49K 10-Q · filed 2017-05-09 | $61.79K derived: sum of 2 quarters · filed 2017-05-09 | $82.26K derived: sum of 3 quarters · filed 2017-05-09 | $102.20K derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2016-12-31 | $30.30K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $50.77K derived: sum of 2 quarters · filed 2017-03-08 | $70.71K derived: sum of 3 quarters · filed 2017-08-09 | $88.00K 10-K · filed 2017-03-08 | ||||
| 2016-09-30 | $20.46K 10-Q · filed 2016-11-10 | $40.41K derived: sum of 2 quarters · filed 2017-08-09 | $57.70K 10-Q · filed 2016-11-10 | $75.99K derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2016-06-30 | $19.95K 10-Q · filed 2017-08-09 | $37.23K 10-Q · filed 2017-08-09 | $55.53K derived: sum of 3 quarters · filed 2017-08-09 | $70.23K derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2016-03-31 | $17.82K 10-Q · filed 2017-05-09 | $17.29K 10-Q · filed 2016-05-13 | $35.58K derived: sum of 2 quarters · filed 2017-05-09 | $50.28K derived: sum of 3 quarters · filed 2017-05-09 | $56.41K derived: sum of 4 quarters · filed 2017-05-09 | |||
| 2015-12-31 | $17.76K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $32.46K derived: sum of 2 quarters · filed 2017-03-08 | $38.58K derived: sum of 3 quarters · filed 2017-03-08 | $44.00K 10-K · filed 2017-03-08 | $43.94K 10-K · filed 2016-03-28 | |||
| 2015-09-30 | $14.70K 10-Q · filed 2016-11-10 | $20.82K derived: sum of 2 quarters · filed 2016-11-10 | $26.24K 10-Q · filed 2016-11-10 | $31.56K derived: sum of 4 quarters · filed 2016-11-10 | ||||
| 2015-06-30 | $6.12K 10-Q · filed 2016-08-12 | $11.54K 10-Q · filed 2016-08-12 | $16.86K derived: sum of 3 quarters · filed 2016-08-12 | $21.72K derived: sum of 4 quarters · filed 2016-08-12 | ||||
| 2015-03-31 | $5.37K 10-Q · filed 2016-05-13 | $10.74K derived: sum of 2 quarters · filed 2016-05-13 | $15.60K derived: sum of 3 quarters · filed 2016-05-13 | |||||
| 2014-12-31 | $5.37K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $10.22K derived: sum of 2 quarters · filed 2016-03-28 | $10.40K 10-K · filed 2016-03-28 | |||||
| 2014-09-30 | $4.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $5.03K 10-Q · filed 2015-11-10 | ||||||
| 2014-06-30 | $180.00 10-Q · filed 2015-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |